← Human Trials & Peer-Reviewed Studies
Effects of Multi-Ingredient Pre-Workout Supplement and Caffeine on Bench Press Performance: A Single-Blind Cross-Over Study.
Plain-language guide to PMID 35565718 (2022): double-blind and single-blind clinical trial of Copper (Supplement).
Key Facts
- PMID
- 35565718
- Journal
- Nutrients
- Year
- 2022
- Study type
- Clinical Trial
- Authors
- Kruszewski M et al. (6 authors)
- DOI
- 10.3390/nu14091750
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Copper (Supplement), published as a clinical trial.
A group of fifteen resistance-trained males, weighing 83.92 ± 8.95 kg and having an average of 5.6 ± 3.38 years of training experience, tested their bench press 10 repetition maximum (79.01 ± 12.13).
Who Took Part
PubMed tags the participants as men only.
In a cross-over manner, they participated in two sessions where they were blinded to the order of supplementation they were given: either a MIPS including caffeine or caffeine alone.
How the Study Was Run
In design terms this was a double-blind, single-blind and crossover study.
As a double-blind Copper (Supplement) study, the assignments were hidden from both participants and investigators until the end.
Only one side, usually the participants, was kept unaware of whether Copper (Supplement) was given.
In the crossover set-up each of the participants took both Copper (Supplement) and the comparison in turn, acting as their own control.
What Was Measured
A group of fifteen resistance-trained males, weighing 83.92 ± 8.95 kg and having an average of 5.6 ± 3.38 years of training experience, tested their bench press 10 repetition maximum (79.01 ± 12.13).
The subject headings attached to it are Caffeine, Dietary Supplements, Muscle Strength, Physical Endurance, Resistance Training and Sports Nutritional Physiological Phenomena.
The authors tagged it with the keywords ergogenic aids, multi-ingredient pre-workout supplement, pre-workout supplementation, resistance exercise and strength endurance.
What This Means in Plain Language
The paper is a double-blind, single-blind and crossover study of Copper (Supplement).
The publication is from 2022 (Nutrients), a journal based in Switzerland.
More context: the Copper (Supplement) compound page, all human trials.
Our Notes on the Compound
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.